|
Characteristic
| |
|
Age, years
|
66.5 ± 7.6
|
|
Male gender
|
101 (89.4%)
|
|
Body-mass index, kg/m2
|
28.4 ± 3.9
|
|
Diabetes mellitus
|
33 (29.2%)
|
|
Current smoker
|
15 (13.3%)
|
|
Hypertension
|
88 (77.9%)
|
|
Hyperlipidemia
|
99 (87.6%)
|
|
Acute coronary syndrome*
|
21 (18.6%)
|
|
Heart failure NYHA class 3-4
|
23 (20.4%)
|
|
Preoperative laboratory values
| |
|
Baseline high-density lipoprotein, mg/dL
|
38.4 ± 11.2
|
|
Baseline low-density lipoprotein, mg/dL
|
72.8 ± 30.0
|
|
Baseline creatinine, μmol/L
|
89.0 ± 17.5
|
|
Preoperative medication use
| |
|
Aspirin
|
104 (92.0%)
|
|
Clopidogrel
|
12 (10.6%)
|
|
Statin
|
101 (89.4%)
|
|
Beta-blocker
|
87 (77.0%)
|
|
Angiotensin converting enzyme
| |
|
Inhibitor
|
57 (50.4%)
|
|
Postoperative medication use (at discharge)
| |
|
Aspirin
|
113 (100%)
|
|
Clopidogrel
|
56 (49.6%)
|
|
Statin
|
103 (91.2%)
|
|
Beta-blocker
|
105 (92.9%)
|
|
Angiotensin converting enzyme
| |
|
Inhibitor
|
40 (35.4%)
|
|
Operative details
| |
|
Number of distal anastomoses
|
3.5 ± 0.7
|
|
Left internal thoracic graft
|
112 (99.1%)
|
|
Right internal thoracic graft
|
22 (19.5%)
|
|
Cross-clamp time, min
|
64.5 ± 20.1
|
|
Cardiopulmonary bypass time, min
|
90.1 ± 24.6
|
|
Off-pump surgery
|
4 (3.5%)
|
|
Length of stay
| |
|
Duration in intensive care, days
|
1.4 ± 1.0
|
|
Duration in hospital, days
|
8.7 ± 5.8
|
